Abstract
Aims Heart failure (HF) is associated with multiple co-morbidities which independently influence response to treatment as well as outcomes. This retrospective observational study (January 2020-June 2021) analysed the impact of monthly virtual HF multi-specialty multi-disciplinary team (MDT) meetings to address the management of associated comorbidities and thereby upon provision, cost of care and HF outcomes.
Methods Patients acted as their own controls, with outcomes compared for equal periods (for each patient) pre versus post-MDT meeting. The MDT comprised of HF cardiologists (primary, secondary, tertiary care), HF specialist nurses (hospital, community), nephrologist, endocrinologist, palliative care specialist, chest physician, pharmacist, clinical pharmacologist and geriatrician. Outcome measures were 1) all-cause hospitalisations, 2) outpatient clinic attendances, and 3) cost.
Results 334 patients (mean age 72.5±11 years) were discussed virtually through MDT meetings and follow-up duration was 13.9 ± 4 months. The mean age-adjusted Charlson Co-morbidity Index was 7.6 ± 2.1 and Rockwood Frailty Score was 5.5 ± 1.6. The mean number of clinic attendances prevented was 1.6 ± 0.4. The total cost of funding monthly meetings for the duration of the study was £32400 and the 64 clinic appointments generated cost £9600. The MDT meetings prevented 534 clinic appointments (cost saving £80,100) and reduced all-cause hospitalisations (pre-MDT meeting 1.1±0.4 vs. 0.6±0.1 post-MDT meeting; p<0.001), reduction of 1586 hospital bed-days and cost-savings of £634,400. The total cost-saving to the healthcare system was £672,500.
Conclusion The HF multispecialty virtual MDT model provides integration of care across all tiers of healthcare for HF management and a holistic approach addressing associated co-morbidities. This approach can reduce the need for out-patient attendances and all-cause hospitalisations, leading to significant cost-savings.
What is already known about this subject?Heart failure is associated with several co-morbid health conditions (multi-morbidity) which independently influence outcomes as well as response to treatment.
What does this study add?This study assesses the impact of multispecialty multi-morbidity input into the management of co-morbidities and thereby the effect upon all-cause outcomes.
How might this impact on clinical practice?Results of this study illustrate that multi-speciality management of comorbidities associated with heart failure, may not only improve all-cause outcomes but could also prove to be cost-beneficial.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Multispecialty HF MDT meetings are funded by the Liverpool Single Services Cardio-Respiratory Operation Group, Liverpool Clinical Commissioning Group and Liverpool University Hospitals NHS Foundation Trust
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research Governance Committee (Institutional Review Board) at Liverpool University Hospitals NHS Foundation Trust and Liverpool Health Partners, gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email hani_essa{at}hotmail.com
Email - Lauren.Walker{at}liverpool.ac.uk
Email Kevin.Mohee{at}liverpoolft.nhs.uk
Email Emeka.Oguguo{at}liverpoolft.nhs.uk
Email - Homeyra.Douglas{at}liverpoolft.nhs.uk
Matthew.Kahn{at}lhch.nhs.uk
Archana.Rao{at}lhch.nhs.uk
Email – Justine.Hadcroft{at}liverpoolft.nhs.uk
Email - nick{at}pumpingmarvellous.org
Email - Janet.Bliss{at}livgp.nhs.uk
Email Asan.Akpan{at}liverpoolft.nhs.uk
Email – Christopher.Wong{at}liverpoolft.nhs.uk
Email - Dan.Cuthbertson{at}liverpool.ac.uk
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- HF
- Heart Failure
- MDT
- multidisciplinary team
- IHD
- Ischaemic Heart Disease
- AF
- atrial fibrillation
- HTN
- hypertension
- CKD
- chronic kidney disease
- DM
- diabetes mellitus
- COPD
- chronic obstructive pulmonary disease